VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹61 Cr | ₹88 Cr | ₹59 Cr | ₹37 Cr | ₹24 Cr |
What is the latest Cash Flow from Operating Activities ratio of VIMTA LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2024 | ₹61 Cr |
| Mar2023 | ₹88 Cr |
| Mar2022 | ₹59 Cr |
| Mar2021 | ₹37 Cr |
| Mar2020 | ₹24 Cr |
How is Cash Flow from Operating Activities of VIMTA LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹61 Cr | -30.75 | |
| Mar2023 | ₹88 Cr | 48.87 | |
| Mar2022 | ₹59 Cr | 58.86 | |
| Mar2021 | ₹37 Cr | 52.71 | |
| Mar2020 | ₹24 Cr | - | |
Compare Cash Flow from Operating Activities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,015.9 Cr | -1.6% | 9.5% | -3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -1.6% |
9.5% |
-3.8% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses